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CAS E R E POR T
An insulinoma presenting with hypochondriac delusions
and food refusal
...........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................
Susana Renca, Graça Santos and Joaquim Cerejeira
Centro Hospitalar e Universitário de Coimbra, EPE, Av. Bissaya Barreto – Praceta Prof. Mota Pinto, 3000-075 Coimbra, Portugal
ABSTRACT
The authors report a case of a 68-year-old man with an unrecognized insulinoma manifesting with neuropsy-
chiatric symptoms.
For two years, he presented with unspecified behavior changes, autonomic and neuroglycopenic symptoms,
which led him to be misdiagnosed with a neurologic and psychiatric disorder before the insulinoma was
recognized.
Following neurological alterations in context of hypoglycemia, subsequent to longstanding food refusal, he
was admitted in the psychiatric ward. Despite good global response and normal food intake, hypoglycemic
episodes were still occurring and led to a careful evaluation which permitted the definitive diagnostic.
This case highlights the diagnostic difficulties of medical disorders presenting with clinical features overlapping
neurological and psychiatric syndromes. It also reflects the diagnostic difficulties in rare clinical entities,
particularly in patients previously followed in psychiatry and underlines the need for a constant dialogue and
updating of clinicians.
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Introduction
Although rare, insulinomas are the most common
pancreatic endocrine tumors with an estimated in-
cidence of four cases per million persons/year (Ser-
vice et al., 1991; Mathur et al. 2009).
Common clinical manifestations include a wide
range of neuropsychiatric symptoms secondary to
hypoglycemic episodes resulting from endogenous
hyperinsulinism (Dizon et al., 1999).
Evidence from previous reports suggests that a
significant proportion of cases are misdiagnosed
with a neurologic or psychiatric disorder before the
insulinoma is detected (Harrington et al., 1983;
Dizon et al., 1999; Alemdar et al., 2006). We report
a case of an unrecognized insulinoma manifesting
with hypochondriac delusions and food refusal.
Case report
A 68-year-old male admitted to the emergency de-
partment with acute seizures and right hemiparesis,
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associated with hypoglycemia (plasma glucose: 47
mg/dL), was referred to psychiatric evaluation as
longstanding food refusal was considered to be the
primary cause of the symptoms.
The patient had been presenting, for the last eight
months, hypochondriac delusions of having neck
cancer obstructing his throat together with clogged
bowels despite all the refuting evidence obtained by
clinical and ancillary examinations. These ideas lead
to persistent food avoidance and self-induced fast-
ing with frequent and symptomatic hypoglycemic
episodes.
His past psychiatric history was remarkable only
for a successfully treated depressive episode eight
years before. However, over the last two years, be-
havioral changes were reported consisting in hiding
food and refusing meals associated with frequent
episodes of sweating, slurred speech, and tremu-
lousness that were relieved by forced eating. Asso-
ciated clinical manifestations included self-neglect,
anhedonia, lethargy, isolation, periods of confusion
with disorganized speech, episodes of unrespons-
iveness and attention impairment with significant
difficulties in performing daily tasks.
The patient was admitted to the acute psychiatric
ward with the provisional diagnosis of “depressive
episode with hypochondriac features” and treated
with Venlafaxine 75 mg po id, Risperidone 1 mg
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Figure 1. (Colour online) Episodewith symptomsof hypoglycemia
(Plasma glucose: 42 mg/dL [<55 mg/dL]). Additional workout
was performed.
po 2id, and Alprazolam 0.5 mg po 3id. Within
a week there was a significant improvement in
Brief Psychiatric Rating Scale (BPRS) scores
from baseline particularly in somatic concern
(6 to 3), anxiety (6 to 2), depression (6 to 3),
and unusual thought content (5 to 2) as well as
an overall improvement in the Hamilton Rating
Scale for Depression (HRSD) (21 to 12). At this
time, the eating behavior was normalized as the
food intake significantly increased from baseline
(900 Kcal/day) to about 1,600 Kcal/day without
the need of further interventions. Despite the
good clinical response, unremitting hypoglycemic
episodes were still occurring even with normal food
intake (Figure 1). Additional workout revealed
inappropriately high serum insulin (9.5 μU/mL
[3 μU/mL]), C-peptide (0.4 nmol/L [0.2
nmol/L]), and proinsulin concentrations (9 pmol/L
[5 pmol/L]) associated with low serum glucose
(42 mg/dL [55 mg/dL]) together with a negative
test for insulin secretagogues. These results obvi-
ated the need of a provocative test (Service, 1999).
A pancreatic head mass with 1.8 cm was evid-
enced by abdominal computerized tomography and
transendoscopic ultrasound. After surgical enucle-
ation, it was histopathologically confirmed to be an
insulinoma showing a distinct immunostaining pat-
tern for proinsulin and insulin compared with adja-
cent normal B cells of pancreatic islets. Six months
after surgery, the patient showed an improvement
in BPRS and HRSD scores in relation to baseline
(68 to 18 and 21 to 8, respectively) with a better
personal and social functioning. During follow-up
no hypoglycemic episodes were detected. As the pa-
tient maintained mild depressive symptoms, the an-
tidepressant was prescribed for one more year.
Discussion
Insulinomas impose a diagnostic challenge as they
present with clinical features overlapping more
common psychiatric syndromes.
These tumors produce high levels of insulin, even
in the presence of hypoglycemia, resulting in a de-
crease in circulating blood glucose. Not surpris-
ingly, since glucose is the major energy substrate in
the adult brain supporting a complexmetabolic pro-
cesses essential for neuronal activity (McCrimmon,
2012) hypoglycemic episodes may induce neuro-
psychiatric symptoms and repeated periods of hy-
poglycemia can mimetize certain psychiatric states.
As reported in other cases (Harrington et al.,
1983; Service et al., 1991; Dizon et al., 1999),
autonomic symptoms were overlooked and taken
as consequent to hypoglycemia. However, this case
is peculiar because the hypoglycemic episodes were
initially judged as secondary to behavioral disturb-
ances with food refusal and prolonged fasting. The
adequate treatment of psychiatric symptoms associ-
ated with persistent episodic hypoglycemia was cru-
cial to clarify the pathophysiology. A delay of two
years occurred between the onset of symptoms and
the correct diagnosis of insulinoma, which is in ac-
cordance with the literature revealing that these pa-
tients are commonly misdiagnosed with psychiatric
and neurologic illnesses (Service et al., 1991; Dizon
et al., 1999; Vig et al., 2001; Ding et al., 2010). This
case highlights the difficulty in accurately recogniz-
ing an insulinoma.
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